CIK 0001680581 · Non-accelerated filer<br>Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474839948
- Phone
- 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- POSASR Other POSASR
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 15 of 27 · 523 filings